Hamilton Lane (HLNE)

Hamilton Lane (HLNE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down t...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire al...

Q3 results showed revenue up 34% year over year, coupled with strong overall profitability, both benefiting from higher incentive fees. Underlying growth in assets under management/advisement was mute...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- #cosettepharma--Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations.

Hamilton Lane Incorporated (NASDAQ:HLNE ) Q3 2025 Earnings Conference Call February 4, 2025 11:00 AM ET Company Participants John Oh - Head of Shareholder Relations Erik Hirsch - Co-CEO Jeff Armbriste...

The headline numbers for Hamilton Lane (HLNE) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street...

Hamilton Lane (HLNE) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $0.71 per share a year ago.

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- #commercial--Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Brad Leonard as Vice President, Generic...